Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 8.46M | $156M | $18.42 | Nov 18, 2024 | Direct |
Tectonic Therapeutic, Inc. | Director, 10%+ Owner | Common Stock | 4.1M | $138M | $33.59 | Oct 22, 2024 | Direct |
Tectonic Therapeutic, Inc. | Director, 10%+ Owner | Common Stock | 310K | $10.4M | $33.59 | Oct 22, 2024 | By LLC |
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 530K | $9.76M | $18.42 | Nov 14, 2024 | Indirect |
Tectonic Therapeutic, Inc. | Director, 10%+ Owner | Common Stock | 186K | $6.25M | $33.59 | Oct 22, 2024 | By Spouse |
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 331K | $6.09M | $18.42 | Nov 14, 2024 | By wife |
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 7.6K | $6K | $0.79 | Apr 8, 2024 | Direct |
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Series B Non-Voting Convertible Preferred Stock | 0 | $0 | $20.00 | Sep 25, 2024 | By wife |
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Series B Non-Voting Convertible Preferred Stock | 0 | $0 | $20.00 | Sep 25, 2024 | Direct |
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Series B Non-Voting Convertible Preferred Stock | 0 | $0 | $20.00 | Sep 25, 2024 | Indirect |
Morphic Holding, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $55.79 | Aug 16, 2024 | By Spouse |
Morphic Holding, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $55.79 | Aug 16, 2024 | Direct |
Morphic Holding, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $55.79 | Aug 16, 2024 | See TAS Partners LLC |
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Warrant (Right to Buy) | 114K | Oct 2, 2024 | Direct | ||
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Warrant (Right to Buy) | 33.4K | Oct 2, 2024 | Indirect | ||
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Warrant (Right to Buy) | 20K | Oct 2, 2024 | By wife | ||
Tectonic Therapeutic, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 11.8K | Jun 20, 2024 | Direct | ||
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Series A Non-Voting Convertible Preferred Stock | 0 | Apr 8, 2024 | Direct | ||
Cartesian Therapeutics, Inc. | Director, 10%+ Owner | Series A Non-Voting Convertible Preferred Stock | 0 | Apr 8, 2024 | Indirect | ||
Morphic Holding, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 0 | Aug 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. | Nov 14, 2024 | 5 | $7.37M | 4 | Nov 18, 2024 | Director, 10%+ Owner |
TECX | Tectonic Therapeutic, Inc. | Oct 22, 2024 | 1 | $10.1M | 4 | Oct 24, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Oct 2, 2024 | 16 | $4.29M | 4 | Oct 4, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Sep 25, 2024 | 6 | $0 | 4 | Sep 27, 2024 | Director, 10%+ Owner |
TECX | Tectonic Therapeutic, Inc. | Sep 24, 2024 | 7 | $1.44M | 4 | Sep 26, 2024 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Aug 16, 2024 | 11 | $0 | 4 | Aug 20, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Aug 12, 2024 | 1 | $102K | 4 | Aug 14, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Jul 2, 2024 | 3 | $47.2M | 4 | Jul 5, 2024 | Director, 10%+ Owner |
TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 3 | $0 | 4 | Jun 24, 2024 | Director, 10%+ Owner |
TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 0 | $0 | 3 | Jun 24, 2024 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Jun 4, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Apr 8, 2024 | 4 | $0 | 4 | Apr 10, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Mar 26, 2024 | 2 | $2.88M | 4 | Mar 26, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Mar 18, 2024 | 1 | $11.4K | 4 | Mar 20, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Mar 14, 2024 | 2 | $666K | 4 | Mar 18, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Jan 17, 2024 | 10 | $11.4K | 4 | Mar 28, 2024 | Director, 10%+ Owner |
RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director, 10%+ Owner |
SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 9 | $59.9M | 4 | Nov 15, 2023 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Jun 28, 2023 | 2 | $0 | 4 | Jun 30, 2023 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | May 3, 2023 | 1 | $47.3M | 4 | May 4, 2023 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Feb 13, 2023 | 2 | $30M | 4 | Feb 13, 2023 | Director, 10%+ Owner |
SELB | SELECTA BIOSCIENCES INC | Jan 2, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director, 10%+ Owner |
SELB | SELECTA BIOSCIENCES INC | Apr 11, 2022 | 2 | $0 | 4 | Apr 13, 2022 | Director, 10%+ Owner |
SELB | SELECTA BIOSCIENCES INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director, 10%+ Owner |
SELB | SELECTA BIOSCIENCES INC | Dec 15, 2021 | 1 | $631K | 4 | Dec 17, 2021 | Director, 10%+ Owner |
SELB | SELECTA BIOSCIENCES INC | Dec 9, 2021 | 3 | $11.7M | 4 | Dec 13, 2021 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Aug 18, 2021 | 7 | $4.21M | 4 | Aug 20, 2021 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | Jun 16, 2021 | 1 | $0 | 4/A | Apr 29, 2022 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | May 24, 2021 | 7 | $6.02M | 4 | May 26, 2021 | Director, 10%+ Owner |
SELB | SELECTA BIOSCIENCES INC | May 24, 2021 | 3 | $7.06M | 4 | May 26, 2021 | Director, 10%+ Owner |
MORF | Morphic Holding, Inc. | May 21, 2021 | 1 | $10.6M | 4 | May 25, 2021 | Director, 10%+ Owner |
SELB | SELECTA BIOSCIENCES INC | May 21, 2021 | 1 | $8.85M | 4 | May 25, 2021 | Director, 10%+ Owner |